NCT02017535View on ClinicalTrials.gov

An Adaptive Treatment Strategy for Adolescent Depression-Continuation

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

October 1, 2018

Study Completion Date

October 1, 2018

Conditions
Adolescent Depression
Interventions
DRUG

Fluoxetine

Prozac (fluoxetine capsules, USP) is a selective serotonin reuptake inhibitor for oral administration.

BEHAVIORAL

Interpersonal Psychotherapy

Type of talk therapy that focuses on an adolescents relationship and communication skills in the context of of their depression.

Trial Locations (1)

55454

University of Minnesota, Department of Psychiatry, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT02017535 - An Adaptive Treatment Strategy for Adolescent Depression-Continuation | Biotech Hunter | Biotech Hunter